Published by Josh White on 15th July 2022
(Sharecast News) - Allergy Therapeutics updated the market on the financial year just ended on Friday, with the phase one 'Peanut PROTECT' trial, incorporating "ground-breaking" VLP technology, proceeding as planned, with site initiation visits imminent.
URL: http://www.digitallook.com/dl/news/story/32824675/...